Award Winners


The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations at ISPOR's conferences. ISPOR Judges evaluated podium and poster presentations within the top 5% of accepted abstracts, which were based on abstract peer reviewed scores, and were eligible for a presentation award. Evaluations of scientific merit were based upon the following criteria:

QUALITY OF RESEARCH STUDY

  • Research design is appropriate and transparent
  • Data sources are appropriate and transparent
  • Data analyses are appropriate and transparent
  • Results are included and are transparent and comprehensible
  • Uncertainty of results is addressed appropriately
  • Conclusions are consistent with the results

QUALITY OF PRESENTATION

  • Objectives/research questions are clearly stated, and objectives are addressed
  • Factual information is kept separate from interpretations or implications / unbiased presentations
  • Implications, as presented, are easy to understand
  • Clarity of presentation

Click through for more information on the criteria used for judging Podiums and Posters.


THE RECIPIENTS ARE…


BEST GENERAL POSTER RESEARCH PRESENTATIONS

 

EE64: Healthcare Resource Utilisation and Medical Costs Among Patients With High-Grade Serous Ovarian Cancer in a Real-Life Setting in Finland: The OCRWE-Finland Study 
Presenting Author: Barbara Mascialino, GSK, Italy 
 
EE347: Treatment Patterns and Healthcare Resource Utilization (HRU) Among Patients With Multiple Sclerosis (MS) in Germany Treated With Nabiximols Between 2010 and 2020 
Presenting Author: Caroleen Drachenberg, Jazz Pharmaceuticals, USA 
 
EE416: Cost-Effectiveness of Pembrolizumab Monotherapy for First-Line Treatment in Adult Patients with Microsatellite Instability High/Mismatch Repair-Deficient Metastatic Colorectal Cancer from a French Perspective 
Presenting Author: Lauren Cagnan, MSD France, France 

 
BEST STUDENT POSTER RESEARCH PRESENTATIONS 

EE569: Axicabtagene Ciloleucel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the Irish Healthcare Setting: Cost-Utility and Value of Information Analysis 
Presenting Author: Niamh Carey, National Centre for Pharmacoeconomics, Ireland 
 
EE604: Cost-Benefit Analysis of the New Jersey Prescription Drug Monitoring Program 
Presenting Author: Rushabh Lagdiwala, Philadelphia College of Pharmacy, USA 
 
PCR174: Valuation of the EQ-5D-3L in Jordan 
Presenting Author: Abeer Al Rabayah, King Hussein Cancer Center, UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Jordan 

PCR210: Quality of Life and Productivity Losses of Dysmenorrhea Patients in Korea 
Presenting Author: Hyuna Yoon, Kyung Hee University, South Korea 

BEST NEW INVESTIGATOR POSTER RESEARCH PRESENTATIONS 

EE111: Cost-Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands 
Presenting Author: Cornelis Boersma, Health-Ecore, Netherlands 
 
EE118: Capturing Patient Value in an Economic Evaluation 
Presenting Author: Fiona Koster, Maasstad Hospital, Netherlands  
 
EE142: The Clinical Benefits and Costs of Potential Cervical Cancer Screening Strategies in the Czech Republic 
Presenting Author: KateĊ™ina Hejcmanová, Institute of Health Information and Statistics of the Czech Republic, Czech Republic 

EPH91: Association Between Mental Disorders and COVID-19 Outcomes in Hospitalized Patients in France: A Retrospective Nationwide Population-Based Study 
Presenting Author: Alexandre Descamps, Université de Paris, Inserm CIC 1417, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, CIC Cochin Pasteur, France 

BEST GENERAL PODIUM RESEARCH PRESENTATIONS 

P29: Using Regression to Represent an Economic Model to Support Sensitivity Analyses 
Presenting Author: Conor Teljeur, Health Information and Quality Authority, Ireland 
 
P30: Incorporating Beliefs on the Relevance of Values Into Meta-Analyses of Health State Utility Values Using the Bayesian Power Prior 
Presenting Author: Anthony Hatswell, Delta Hat, UK 
 
P33: Use of Real-World Evidence in European Medicines Agency Decisions 
Presenting Author: Ulrike Kuchenbecker, PHMR, UK 

BEST STUDENT PODIUM RESEARCH PRESENTATIONS 

P5: Patient Preferences on Decentralization of Clinical Trials: Identifying Attributes in a Focus Group Study 
Presenting Author: Julia Kopanz, University Medical Center Utrecht, Netherlands 
 
P21: Accuracy of Overall Survival (OS) Extrapolations in French Cost-Effectiveness Reports Relative to Updated Data from Randomized Controlled Trials of Immune Checkpoint Inhibitors (ICIS) 
Presenting Author: Aurélie Gueye, Université de Paris-Dauphine, France 
 
P38: One Size Does Not Fit All: Calculating the Cost-Effectiveness of Multiple Indications of Pembrolizumab in the Netherlands 
Presenting Author: Florentine Verbeek, Erasmus University, Institute of Health Policy & Management, Netherlands 

BEST NEW INVESTIGATOR PODIUM RESEARCH PRESENTATIONS 

P37: Impact of Method for Modelling Distant Recurrence (DR) on Cost-Effectiveness (CE) of Nivolumab (NIVO) as an Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma (MIUC) 
Presenting Author: Florian Colrat, Bristol-Myers Squibb SARL, France 
 
P57: Machine Learning-Accelerated Outcomes Research: A Real-World Case Study of Biomarker-Associated Overall Survival in Oncology 
Presenting Author: Corey Benedum, Flatiron Health, USA 
 
P65: Impact of COVID-19 on Hospital Screening, Diagnosis and Treatment Activities Among Prostate and Colorectal Cancer Patients in Canada 
Presenting Author: Frank Shin-Haw Lee, ZS Associates, Canada